Comparison between topical recombinant human epidermal growth factor and
            Aloe vera
            gel in combination with ablative fractional carbon dioxide laser as treatment for striae alba: A randomized double‐blind trial

Wareeporn Disphanurat; Arisa Kaewkes; Worapop Suthiwartnarueput

doi:10.1002/lsm.23052

Comparison between topical recombinant human epidermal growth factor and Aloe vera gel in combination with ablative fractional carbon dioxide laser as treatment for striae alba: A randomized double‐blind trial

Lasers in Surgery and Medicine ◽

10.1002/lsm.23052 ◽

2019 ◽

Vol 52 (2) ◽

pp. 166-175 ◽

Cited By ~ 3

Author(s):

Wareeporn Disphanurat ◽

Arisa Kaewkes ◽

Worapop Suthiwartnarueput

Keyword(s):

Carbon Dioxide ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Carbon Dioxide Laser ◽

Aloe Vera ◽

Double Blind Trial ◽

Double Blind ◽

Aloe Vera Gel ◽

Fractional Carbon Dioxide Laser ◽

Epidermal Growth

Download Full-text

A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum

Cancer Prevention Research ◽

10.1158/1940-6207.capr-14-0148 ◽

2015 ◽

Vol 8 (3) ◽

pp. 222-230 ◽

Cited By ~ 1

Author(s):

Daniel L. Gillen ◽

Frank L. Meyskens ◽

Timothy R. Morgan ◽

Jason A. Zell ◽

Robert Carroll ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Aberrant Crypt Foci ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

Epidermal Growth ◽

Growth Factor Receptor Signaling

Download Full-text

Faculty Opinions recommendation of Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1065847.518790 ◽

2007 ◽

Author(s):

Aimee Payne

Keyword(s):

Randomized Controlled Trial ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Controlled Trial ◽

Pemphigus Vulgaris ◽

Skin Lesions ◽

Double Blind ◽

Randomized Controlled ◽

Epidermal Growth

Download Full-text

Effectiveness of a synthetic human recombinant epidermal growth factor in diabetic patients wound healing : Pilot , double‐blind , randomized clinical controlled trial

Wound Repair and Regeneration ◽

10.1111/wrr.12969 ◽

2021 ◽

Author(s):

Bianca Campos Oliveira ◽

Beatriz Guitton Renaud Baptista Oliveira ◽

Gabriela Deutsch ◽

Fernanda Soares Pessanha ◽

Selma Rodrigues Castilho

Keyword(s):

Wound Healing ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Controlled Trial ◽

Diabetic Patients ◽

Double Blind ◽

Epidermal Growth

Download Full-text

Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non‐segmental vitiligo on non‐facial areas: A randomized half‐body, double‐blind, placebo‐controlled, comparative study

Dermatologic Therapy ◽

10.1111/dth.15198 ◽

2021 ◽

Author(s):

Silada Kanokrungsee ◽

Saranya Khunkhet ◽

Salinee Rojhirunsakool ◽

Kamonwan Thadvibun ◽

Thanyapat Sahaspot

Keyword(s):

Carbon Dioxide ◽

Combination Therapy ◽

Comparative Study ◽

Carbon Dioxide Laser ◽

Ultraviolet B ◽

Triple Combination ◽

Double Blind ◽

Triple Combination Therapy ◽

Double Blind Placebo ◽

Fractional Carbon Dioxide Laser

Download Full-text

A randomized, double-blind study of PF-05280014 (a potential biosimilar) vs trastuzumab, both given with docetaxel (D) and carboplatin (C), as neoadjuvant treatment for operable human epidermal growth factor receptor 2-positive (HER2+) breast cancer

Annals of Oncology ◽

10.1093/annonc/mdx362.005 ◽

2017 ◽

Vol 28 ◽

pp. v45 ◽

Cited By ~ 3

Author(s):

P.E. Lammers ◽

M. Dank ◽

R. Masetti ◽

R. Abbas ◽

F. Hilton ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Neoadjuvant Treatment ◽

Growth Factor Receptor ◽

Double Blind Study ◽

Double Blind ◽

Her2 Breast Cancer ◽

Epidermal Growth

Download Full-text

Topical doxycycline foam 4% for prophylactic management of epidermal growth factor receptor inhibitor skin toxicity: an exploratory phase 2, randomized, double-blind clinical study

Supportive Care in Cancer ◽

10.1007/s00520-018-4600-8 ◽

2019 ◽

Vol 27 (8) ◽

pp. 3027-3033 ◽

Cited By ~ 1

Author(s):

Einat Shacham Shmueli ◽

Ravit Geva ◽

Nirit Yarom ◽

Ayala Hubert ◽

Rita Keynan ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Clinical Study ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Skin Toxicity ◽

Phase 2 ◽

Double Blind ◽

Epidermal Growth ◽

Receptor Inhibitor

Download Full-text

Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial

The Lancet Oncology ◽

10.1016/s1470-2045(05)70176-5 ◽

2005 ◽

Vol 6 (6) ◽

pp. 383-391 ◽

Cited By ~ 133

Author(s):

Andreas Polychronis ◽

H Dudley Sinnett ◽

Dimitri Hadjiminas ◽

Hemant Singhal ◽

Janine L Mansi ◽

...

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Oestrogen Receptor ◽

Randomised Trial ◽

Growth Factor Receptor ◽

Double Blind ◽

Double Blind Placebo ◽

Epidermal Growth

Download Full-text

Review of "Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study"

10.14322/publons.r4300295 ◽

2019 ◽

Author(s):

Olga Rebrova

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Diabetic Foot ◽

Blind Study ◽

Foot Ulcers ◽

Double Blind Study ◽

Diabetic Foot Ulcers ◽

Double Blind ◽

Human Epidermal Growth Factor ◽

Epidermal Growth

Download Full-text

Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2018.06.002 ◽

2018 ◽

Vol 142 ◽

pp. 335-344 ◽

Cited By ~ 19

Author(s):

Kwang Hwan Park ◽

Seung Hwan Han ◽

Joon Pio Hong ◽

Seung-Kyu Han ◽

Doo-Hyung Lee ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Diabetic Foot ◽

Controlled Trial ◽

Phase Iii ◽

Foot Ulcers ◽

Diabetic Foot Ulcers ◽

Double Blind ◽

Epidermal Growth

Download Full-text

Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2006.01873.x ◽

2007 ◽

Vol 21 (1) ◽

pp. 79-84 ◽

Cited By ~ 27

Author(s):

MN Tabrizi ◽

C Chams-Davatchi ◽

N Esmaeeli ◽

P Noormohammadpoor ◽

F Safar ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Controlled Trial ◽

Pemphigus Vulgaris ◽

Skin Lesions ◽

Double Blind ◽

Randomized Controlled ◽

Epidermal Growth

Download Full-text